Skip to main content
. Author manuscript; available in PMC: 2017 Apr 4.
Published in final edited form as: Thromb Haemost. 2017 Jan 19;117(4):691–699. doi: 10.1160/TH16-11-0834

Fig. 3. Cluster analysis.

Fig. 3

This analysis demonstrated that mortality risk was higher in patients with high plasma levels of VWFAg and VWFAc levels (~7.3 and 1.4 times, respectively) and low plasma levels of ADAMTS13 activity (2.1 times).